Delivery Order SPE2DB24D2010-SPE2DB25FAAUE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,337.04 to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets (100-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The performance location...
- The Defense Logistics Agency awarded a delivery order valued at $2,351.70 to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets (100-count packages) under a firm fixed-price contract. The award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and represents a non-set-aside, competitively awarded transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,906.61 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. The contract employs firm fixed pricing under a non-competitive, non-set-aside delivery order structure. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count packages) with a ceiling value of $2,107.09. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and holds a substantial...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.32 to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets (100 count) on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cipro 500 mg tablets (100 count) at a ceiling value of $1,567.80. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cipro (ciprofloxacin) 250 mg tablets in quantities of 100 units, with a contract ceiling value of $1,564.92. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a pediatric or smaller-quantity pharmaceutical procurement utilizing AmerisourceBergen's existing contract vehicle. The award was not designated as a set-aside and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100 count) with a contract value of $3,574.21. This competitively awarded, non-set-aside delivery order was issued on September 30, 2025, with an ultimate completion date of October 1, 2025, and reflects a firm fixed-price arrangement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count units) with a ceiling value of $2,502.88. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by July 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAUEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,567.80 to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets in quantities of 100 units. This contract, issued on August 12, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver the pharmaceutical product to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Ciprofloxacin, an antibiotic medication, is a standard pharmaceutical commodity within the company's extensive portfolio of federal medical deliveries, which includes specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/12/25 |